ARRO Autogas opens 20th propane refueling station in California
Energy, Latest newsARRO Autogas, a subsidiary of Paso Robles-based Delta Liquid Energy, opened its 20th refueling station in California, providing propane fuel for fleet vehicles like school buses. The new station is located in Exeter and was opened in partnership with the San Joaquin Valley Clean Cities Coalition. “We provide propane for an awful lot of engines Read More →
2016 Spirit of Small Business Awards winners announced
Latest newsThe Pacific Coast Business Times is pleased to announce our 2016 class of Spirit of Small Business Awards winners. This annual special section, now in its 14th year, celebrates small-business ownership and entrepreneurship in the Tri-Counties. The report published with the July 22 print edition. The winners will be honored at an awards luncheon on Friday, August 19 at Bacara Read More →
Amgen settles lawsuit, says biosimilar works as well as Herceptin
Health Care & Life Science, Latest newsAmgen settled a lawsuit and released positive news about a breast cancer biosimilar this week. The Thousand Oaks-based biotech giant said July 20 the company reached a settlement stemming from a class action lawsuit involving shareholders who sued the company over shares bought from the company between April 22, 2004 and May 10, 2007. Amgen Read More →
Citizens Business Bank second quarter net income down from 2015
Banking & Finance, Banking Industry, Earnings, Latest newsCVB Financial Corp. and its subsidiary Citizens Business Bank reported $25.5 million net income for the second quarter of 2016, or 23 cents per share. That was down from $26.8 million for the second quarter of 2015, or 25 cents per share. Citizens Business Bank completed the integration of County Commerce Bank in the second Read More →
FDA declines to approve Novartis biosimilar for Amgen’s Neulasta
Health Care & Life Science, Latest newsThe Food and Drug Administration has declined for now to approve a copycat version of Amgen’s blockbuster drug Neulasta. Reuters reported July 19 that the FDA sent a letter to Swiss pharmaceutical Novartis at the end of June saying it was declining to approve the drug for now. Neulasta, made by Thousand Oaks-based biotech giant Read More →








